Literature DB >> 9555726

Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA.

L Good1, P E Nielsen.   

Abstract

Peptide nucleic acid (PNA) is a DNA mimic with attractive properties for developing improved gene-targeted antisense agents. To test this potential of PNA in bacteria, PNAs were designed to target the start codon regions of the Escherichia coli beta-galactosidase and beta-lactamase genes. Dose-dependent and specific gene inhibition was observed in vitro using low nanomolar PNA concentrations and in vivo using low micromolar concentrations. Inhibition was more efficient for a permeable E. coli strain relative to wild-type K-12. The potency of the anti-beta-lactamase PNAs was abolished by a six base substitution, and inhibition could be re-established using a PNA with compensating base changes. Antisense inhibition of the beta-lactamase gene was sufficient to sensitize resistant cells to the antibiotic ampicillin. The results demonstrate gene- and sequence-specific antisense inhibition in E. coli and open possibilities for antisense antibacterial drugs and gene function analyses in bacteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555726     DOI: 10.1038/nbt0498-355

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  43 in total

1.  Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.

Authors:  C Torres Viera; S Tsiodras; H S Gold; E P Coakley; C Wennersten; G M Eliopoulos; R C Moellering; R T Inouye
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

Review 3.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

4.  Antisense downregulation of sigma(32) as a transient metabolic controller in Escherichia coli: effects on yield of active organophosphorus hydrolase.

Authors:  R Srivastava; H J Cha; M S Peterson; W E Bentley
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 5.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

6.  In situ hybridization of Prochlorococcus and Synechococcus (marine cyanobacteria) spp. with RRNA-targeted peptide nucleic acid probes.

Authors:  A Z Worden; S W Chisholm; B J Binder
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

7.  Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection.

Authors:  Y Ji; A Marra; M Rosenberg; G Woodnutt
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

Review 8.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

9.  Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa.

Authors:  Anubrata Ghosal; Peter E Nielsen
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486

10.  Blockade of plasmid replication mediated by peptide nucleic acids.

Authors:  Michael R Liebling; Nainn-Tsyr Jou; Wayne Fang; James S Louie
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.